Laboratorios Farmaceuticos ROVI SA
MAD:ROVI
Wall Street
Price Targets
ROVI Price Targets Summary
Laboratorios Farmaceuticos ROVI SA
According to Wall Street analysts, the average 1-year price target for
ROVI
is 77.97 EUR
with a low forecast of 65.55 EUR and a high forecast of 96.6 EUR.
Operating Income
Forecast
Operating Income Estimate
Laboratorios Farmaceuticos ROVI SA
For the last 8 years the
compound annual growth rate for
Laboratorios Farmaceuticos ROVI SA's operating income is
26%.
The projected
CAGR
for the next 3 years is
23%.
Net Income
Forecast
Net Income Estimate
Laboratorios Farmaceuticos ROVI SA
For the last 8 years the
compound annual growth rate for
Laboratorios Farmaceuticos ROVI SA's net income is
23%.
The projected
CAGR
for the next 3 years is
31%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ROVI's stock price target?
Price Target
77.97
EUR
According to Wall Street analysts, the average 1-year price target for
ROVI
is 77.97 EUR
with a low forecast of 65.55 EUR and a high forecast of 96.6 EUR.
What is Laboratorios Farmaceuticos ROVI SA's Revenue forecast?
Projected CAGR
11%
For the last 8 years the
compound annual growth rate for
Laboratorios Farmaceuticos ROVI SA's revenue is
14%.
The projected
CAGR
for the next 3 years is
11%.
What is Laboratorios Farmaceuticos ROVI SA's Operating Income forecast?
Projected CAGR
23%
For the last 8 years the
compound annual growth rate for
Laboratorios Farmaceuticos ROVI SA's operating income is
26%.
The projected
CAGR
for the next 3 years is
23%.
What is Laboratorios Farmaceuticos ROVI SA's Net Income forecast?
Projected CAGR
31%
For the last 8 years the
compound annual growth rate for
Laboratorios Farmaceuticos ROVI SA's net income is
23%.
The projected
CAGR
for the next 3 years is
31%.
You don't have any saved screeners yet
